Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | BioPharma Credit PLC (Ordinary Share) | +19.85% |
NAV | BioPharma Credit PLC (Ordinary Share) | +9.09% |
Morningstar's Benchmark | No benchmark | -- |
Key statistics
As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.89, -5.72% below its 52-week high of 0.944, set on Jan 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 1.20bn |
---|---|
Market cap | 1.05bn USD |
Total assets | 1.21bn USD |
Total expense ratio | 1.15% |
High | 0.896 |
Low | 0.888 |
Previous close | 0.882 |
Average volume | 981.71k |
---|---|
YTD Change | +5.95% |
Beta | 0.2893 |
Diluted NAV (est) | 1.01 |
Diluted NAV (last pub) | 0.998 |
Premium/Discount | -12.31% |
Net Gearing | 0.00% |
Annual div (ADY) | 0.07 USD |
---|---|
Annual div yield (ADY) | 7.94% |
Div ex-date | Jul 04 2024 |
Div pay-date | Jul 31 2024 |
Data delayed at least 20 minutes, as of Sep 16 2024 11:43 BST.
More ▼